These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 31575379

  • 21. Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic.
    Yanagisawa S, Inden Y, Yoshida N, Kato H, Miyoshi-Fujii A, Mizutani Y, Ito T, Kamikubo Y, Kanzaki Y, Hirai M, Murohara T.
    Heart Vessels; 2016 Sep; 31(9):1553-61. PubMed ID: 26498940
    [Abstract] [Full Text] [Related]

  • 22. Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.
    Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M, Baluta MM, Proietti M, Tavazzi L, Maggioni AP, Lip GYH, EORP-AF General Pilot Registry InvestigatorsCardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy..
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):566-572. PubMed ID: 29345382
    [Abstract] [Full Text] [Related]

  • 23. Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation.
    Lee HJ, Choi EK, Han KD, Lee E, Moon I, Lee SR, Cha MJ, Oh S, Lip GYH.
    Heart Rhythm; 2020 Mar; 17(3):365-371. PubMed ID: 31585180
    [Abstract] [Full Text] [Related]

  • 24. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
    Lee SR, Choi EK, Han KD, Cha MJ, Oh S.
    Int J Cardiol; 2017 Oct 15; 245():149-155. PubMed ID: 28757090
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Trajectories of BMI change impact glucose and insulin metabolism.
    Walsh EI, Shaw J, Cherbuin N.
    Nutr Metab Cardiovasc Dis; 2018 Mar 15; 28(3):243-251. PubMed ID: 29361342
    [Abstract] [Full Text] [Related]

  • 31. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC, Yang YY, Chuang SL, Yu CC, Lin LY.
    Cardiovasc Diabetol; 2021 Jul 23; 20(1):148. PubMed ID: 34301257
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and ≥60 years.
    Kim IS, Choi YJ, Choi EY, Min PK, Yoon YW, Lee BK, Hong BK, Rim SJ, Kwon HM, Kim JY.
    PLoS One; 2021 Jul 23; 16(11):e0258770. PubMed ID: 34793457
    [Abstract] [Full Text] [Related]

  • 36. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ, Yang YM, Zhu J, Wang J, Wu S, Zhang H, Shao XH, Ren JM.
    Nutr Metab Cardiovasc Dis; 2020 Nov 27; 30(12):2242-2251. PubMed ID: 32900569
    [Abstract] [Full Text] [Related]

  • 37. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.
    Sivasambu B, Balouch MA, Zghaib T, Bajwa RJ, Chrispin J, Berger RD, Ashikaga H, Nazarian S, Marine JE, Calkins H, Spragg DD.
    J Cardiovasc Electrophysiol; 2018 Feb 27; 29(2):239-245. PubMed ID: 29131442
    [Abstract] [Full Text] [Related]

  • 38. Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.
    Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J.
    Cardiovasc Diabetol; 2015 Jan 15; 14():5. PubMed ID: 25589001
    [Abstract] [Full Text] [Related]

  • 39. The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor.
    Chan YH, Chen SW, Chao TF, Kao YW, Huang CY, Chu PH.
    Cardiovasc Diabetol; 2021 Apr 30; 20(1):93. PubMed ID: 33941171
    [Abstract] [Full Text] [Related]

  • 40. Obesity and the risk of new-onset atrial fibrillation.
    Wang TJ, Parise H, Levy D, D'Agostino RB, Wolf PA, Vasan RS, Benjamin EJ.
    JAMA; 2004 Nov 24; 292(20):2471-7. PubMed ID: 15562125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.